| DIRECT COMPETITOR COMPARISON | |
| RDY | Pvt1 | Pvt2 | TEVA | Industry | | Market Cap: | 4.09B | N/A | N/A | 46.57B | 161.24M | | Employees: | 11,228 | 12,1741 | 7,3002 | 38,307 | 103 | | Qtrly Rev Growth (yoy): | 13.70% | N/A | N/A | 24.90% | 20.50% | | Revenue (ttm): | 1.60B | 943.60M1 | 500.00K2 | 12.95B | 46.74M | | Gross Margin (ttm): | 53.69% | N/A | N/A | 55.30% | 68.58% | | EBITDA (ttm): | 405.42M | N/A | N/A | 3.94B | -7.12M | | Oper Margins (ttm): | 19.75% | N/A | N/A | 24.35% | 2.25% | | Net Income (ttm): | -58.40M | N/A | N/A | 953.00M | N/A | | EPS (ttm): | -0.35 | N/A | N/A | 1.093 | -0.17 | | P/E (ttm): | N/A | N/A | N/A | 48.36 | 17.12 | | PEG (5 yr expected): | 1.01 | N/A | N/A | 0.98 | 1.04 | | P/S (ttm): | 2.51 | N/A | N/A | 3.60 | 4.17 |
|
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 56.37 | -0.23% | 57.05B | 12.29 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 47.03 | 0.23% | 13.60B | 15.74 | | Genzyme Corp. | GENZ | 50.67 | -0.78% | 13.45B | 28.89 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 46.19 | -0.79% | 41.57B | 17.86 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 49.7401 | -0.42% | 8.87B | 1015.10 | | Teva Pharmaceutical Industries Limited | TEVA | 52.86 | -0.04% | 46.57B | 48.36 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 37.10 | 0.38% | 3.94B | 19.12 | | Barr Pharmaceuticals, Inc. | Private - View Profile | | King Pharmaceuticals Inc. | KG | 11.815 | -1.13% | 2.93B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 17.89 | -0.67% | 5.47B | 109.75 | | Pfizer Inc. | PFE | 18.23 | -0.11% | 147.11B | 15.14 | | Johnson & Johnson | JNJ | 62.90 | 0.02% | 173.55B | 13.74 | | GlaxoSmithKline plc | GSK | 41.41 | -2.01% | 104.97B | 13.15 | | Sanofi-Aventis | SNY | 37.97 | -1.20% | 99.14B | N/A |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Novartis AG | NVS | 55.51 | 0.23% | 126.07B | 16.62 | | RHHBY.PK | 41.00 | -1.11% | N/A | N/A | | AstraZeneca plc | AZN | 44.79 | -1.10% | 64.95B | 8.99 | | Abbott Laboratories | ABT | 54.50 | 0.78% | 84.30B | 14.77 | | Bristol-Myers Squibb Co. | BMY | 25.348 | -0.13% | 50.21B | 13.11 |
|
| NEWS ON DIRECT COMPETITORS | |
|
|
|